BrainCheck is positioned as a software-only cognitive screening platform with FDA clearance, targeting rapid in-clinic assessment across dementia, concussion, and general cognitive decline without requiring specialized neuropsychological staff. Its differentiation lies in clinical workflow integration and regulatory status rather than novel biomarker technology, placing it in the digital cognitive assessment tier alongside Cogstate and Cambridge Cognition.